Financial News

Financial Report: AbbVie

HUMIRA drives growth in the quarter

AbbVie

1Q Revenues: $6.0 billion (+18%)

1Q Earnings: $1.3 billion (+32%)

Comments: HUMIRA sales were $3.6 billion, up 15%. IMBRUVICA revenue was $381 million, with U.S. sales of $325 million and international profit sharing of $56 million for the quarter. Viekira sales were $414 million, up 79%. Creon sales were up 18% to $150 million. Synagis sales were down 5% to $319 million. Synthroid sales were down 2% to $182 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters